Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Int J Mol Sci ; 24(6)2023 Mar 13.
Artigo em Inglês | MEDLINE | ID: mdl-36982574

RESUMO

Single-cell RNA sequencing (RNA-seq) has been demonstrated to be a proven method for quantifying gene-expression heterogeneity and providing insight into the transcriptome at the single-cell level. When combining multiple single-cell transcriptome datasets for analysis, it is common to first correct the batch effect. Most of the state-of-the-art processing methods are unsupervised, i.e., they do not utilize single-cell cluster labeling information, which could improve the performance of batch correction methods, especially in the case of multiple cell types. To better utilize known labels for complex dataset scenarios, we propose a novel deep learning model named IMAAE (i.e., integrating multiple single-cell datasets via an adversarial autoencoder) to correct the batch effects. After conducting experiments with various dataset scenarios, the results show that IMAAE outperforms existing methods for both qualitative measures and quantitative evaluation. In addition, IMAAE is able to retain both corrected dimension reduction data and corrected gene expression data. These features make it a potential new option for large-scale single-cell gene expression data analysis.


Assuntos
Perfilação da Expressão Gênica , Análise de Célula Única , Perfilação da Expressão Gênica/métodos , Análise de Sequência de RNA/métodos , Análise de Célula Única/métodos , Análise por Conglomerados , Transcriptoma
2.
J Digit Imaging ; 35(2): 153-161, 2022 04.
Artigo em Inglês | MEDLINE | ID: mdl-35013826

RESUMO

Anomaly detection has been applied in the various disease of medical practice, such as breast cancer, retinal, lung lesion, and skin disease. However, in real-world anomaly detection, there exist a large number of healthy samples, and but very few sick samples. To alleviate the problem of data imbalance in anomaly detection, this paper proposes an unsupervised learning method for deep anomaly detection based on an improved adversarial autoencoder, in which a module called chain of convolutional block (CCB) is employed instead of the conventional skip-connections used in adversarial autoencoder. Such CCB connections provide considerable advantages via direct connections, not only preserving both global and local information but also alleviating the problem of semantic disparity between the encoding features and the corresponding decoding features. The proposed method is thus able to capture the distribution of normal samples within both image space and latent vector space. By means of minimizing the reconstruction error within both spaces during training phase, higher reconstruction error during test phase is indicative of an anomaly. Our method is trained only on the healthy persons in order to learn the distribution of normal samples and can detect sick samples based on high deviation from the distribution of normality in an unsupervised way. Experimental results for multiple datasets from different fields demonstrate that the proposed method yields superior performance to state-of-the-art methods.


Assuntos
Diagnóstico por Imagem , Humanos
3.
Mol Pharm ; 15(10): 4398-4405, 2018 10 01.
Artigo em Inglês | MEDLINE | ID: mdl-30180591

RESUMO

Modern computational approaches and machine learning techniques accelerate the invention of new drugs. Generative models can discover novel molecular structures within hours, while conventional drug discovery pipelines require months of work. In this article, we propose a new generative architecture, entangled conditional adversarial autoencoder, that generates molecular structures based on various properties, such as activity against a specific protein, solubility, or ease of synthesis. We apply the proposed model to generate a novel inhibitor of Janus kinase 3, implicated in rheumatoid arthritis, psoriasis, and vitiligo. The discovered molecule was tested in vitro and showed good activity and selectivity.


Assuntos
Descoberta de Drogas/métodos , Aprendizado de Máquina , Animais , Humanos , Janus Quinase 3/metabolismo , Redes Neurais de Computação
4.
J Cheminform ; 14(1): 84, 2022 Dec 12.
Artigo em Inglês | MEDLINE | ID: mdl-36510307

RESUMO

Deep learning (DL) and machine learning contribute significantly to basic biology research and drug discovery in the past few decades. Recent advances in DL-based generative models have led to superior developments in de novo drug design. However, data availability, deep data processing, and the lack of user-friendly DL tools and interfaces make it difficult to apply these DL techniques to drug design. We hereby present ReMODE (Receptor-based MOlecular DEsign), a new web server based on DL algorithm for target-specific ligand design, which integrates different functional modules to enable users to develop customizable drug design tasks. As designed, the ReMODE sever can construct the target-specific tasks toward the protein targets selected by users. Meanwhile, the server also provides some extensions: users can optimize the drug-likeness or synthetic accessibility of the generated molecules, and control other physicochemical properties; users can also choose a sub-structure/scaffold as a starting point for fragment-based drug design. The ReMODE server also enables users to optimize the pharmacophore matching and docking conformations of the generated molecules. We believe that the ReMODE server will benefit researchers for drug discovery. ReMODE is publicly available at http://cadd.zju.edu.cn/relation/remode/ .

5.
Med Image Anal ; 72: 102090, 2021 08.
Artigo em Inglês | MEDLINE | ID: mdl-34004494

RESUMO

Brain graphs (i.e, connectomes) constructed from medical scans such as magnetic resonance imaging (MRI) have become increasingly important tools to characterize the abnormal changes in the human brain. Due to the high acquisition cost and processing time of multimodal MRI, existing deep learning frameworks based on Generative Adversarial Network (GAN) focused on predicting the missing multimodal medical images from a few existing modalities. While brain graphs help better understand how a particular disorder can change the connectional facets of the brain, synthesizing a target brain multigraph (i.e, multiple brain graphs) from a single source brain graph is strikingly lacking. Additionally, existing graph generation works mainly learn one model for each target domain which limits their scalability in jointly predicting multiple target domains. Besides, while they consider the global topological scale of a graph (i.e., graph connectivity structure), they overlook the local topology at the node scale (e.g., how central a node is in the graph). To address these limitations, we introduce topology-aware graph GAN architecture (topoGAN), which jointly predicts multiple brain graphs from a single brain graph while preserving the topological structure of each target graph. Its three key innovations are: (i) designing a novel graph adversarial auto-encoder for predicting multiple brain graphs from a single one, (ii) clustering the encoded source graphs in order to handle the mode collapse issue of GAN and proposing a cluster-specific decoder, (iii) introducing a topological loss to force the prediction of topologically sound target brain graphs. The experimental results using five target domains demonstrated the outperformance of our method in brain multigraph prediction from a single graph in comparison with baseline approaches.


Assuntos
Encéfalo , Conectoma , Encéfalo/diagnóstico por imagem , Humanos , Imageamento por Ressonância Magnética , Redes Neurais de Computação
6.
Med Image Anal ; 68: 101902, 2021 02.
Artigo em Inglês | MEDLINE | ID: mdl-33338871

RESUMO

Developing predictive intelligence in neuroscience for learning how to generate multimodal medical data from a single modality can improve neurological disorder diagnosis with minimal data acquisition resources. Existing deep learning frameworks are mainly tailored for images, which might fail in handling geometric data (e.g., brain graphs). Specifically, predicting a target brain graph from a single source brain graph remains largely unexplored. Solving such problem is generally challenged with domain fracturecaused by the difference in distribution between source and target domains. Besides, solving the prediction and domain fracture independently might not be optimal for both tasks. To address these challenges, we unprecedentedly propose a Learning-guided Graph Dual Adversarial Domain Alignment (LG-DADA) framework for predicting a target brain graph from a source brain graph. The proposed LG-DADA is grounded in three fundamental contributions: (1) a source data pre-clustering step using manifold learning to firstly handle source data heterogeneity and secondly circumvent mode collapse in generative adversarial learning, (2) a domain alignment of source domain to the target domain by adversarially learning their latent representations, and (3) a dual adversarial regularization that jointly learns a source embedding of training and testing brain graphs using two discriminators and predict the training target graphs. Results on morphological brain graphs synthesis showed that our method produces better prediction accuracy and visual quality as compared to other graph synthesis methods.


Assuntos
Encéfalo , Encéfalo/diagnóstico por imagem , Humanos
7.
Front Pharmacol ; 11: 269, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-32362822

RESUMO

Gene expression profiles are useful for assessing the efficacy and side effects of drugs. In this paper, we propose a new generative model that infers drug molecules that could induce a desired change in gene expression. Our model-the Bidirectional Adversarial Autoencoder-explicitly separates cellular processes captured in gene expression changes into two feature sets: those related and unrelated to the drug incubation. The model uses related features to produce a drug hypothesis. We have validated our model on the LINCS L1000 dataset by generating molecular structures in the SMILES format for the desired transcriptional response. In the experiments, we have shown that the proposed model can generate novel molecular structures that could induce a given gene expression change or predict a gene expression difference after incubation of a given molecular structure. The code of the model is available at https://github.com/insilicomedicine/BiAAE.

9.
Neural Netw ; 119: 222-234, 2019 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-31472289

RESUMO

Anomaly detection in hyperspectral images (HSIs) faces various levels of difficulty due to the high dimensionality, redundant information and deteriorated bands. To address these problems, we propose a novel unsupervised feature representation approach by incorporating a spectral constraint strategy into adversarial autoencoders (AAE) without any prior knowledge in this paper. Our approach, called SC_AAE (spectral constraint AAE), is based on the characteristics of HSIs to obtain better discrimination represented by hidden nodes. To be specific, we adopt a spectral angle distance into the loss function of AAE to enforce spectral consistency. Considering the different contribution rates of each hidden node to anomaly detection, we individually fuse the hidden nodes by an adaptive weighting method. A bi-layer architecture is then designed to suppress the variational background (BKG) while preserving features of anomalies. The experimental results demonstrate that our proposed method outperforms the state-of-the-art methods.


Assuntos
Processamento de Imagem Assistida por Computador , Aprendizado de Máquina
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa